AstraZeneca PLCAZNNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P36
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.04% |
| Q3 2025 | 3.39% |
| Q2 2025 | 5.61% |
| Q1 2025 | -6.73% |
| Q4 2024 | 16.04% |
| Q3 2024 | -2.52% |
| Q2 2024 | 2.81% |
| Q1 2024 | 7.67% |
| Q4 2023 | 3.39% |
| Q3 2023 | -0.62% |
| Q2 2023 | 5.37% |
| Q1 2023 | 8.03% |
| Q4 2022 | 3.84% |
| Q3 2022 | 2.92% |
| Q2 2022 | -1.35% |
| Q1 2022 | 6.67% |
| Q4 2021 | 20.90% |
| Q3 2021 | 1.33% |
| Q2 2021 | 10.50% |
| Q1 2021 | -7.29% |
| Q4 2020 | 13.00% |
| Q3 2020 | -1.57% |
| Q2 2020 | 7.24% |
| Q1 2020 | -6.66% |
| Q4 2019 | 4.57% |
| Q3 2019 | 6.20% |
| Q2 2019 | 9.12% |
| Q1 2019 | -8.74% |
| Q4 2018 | 14.16% |
| Q3 2018 | 1.06% |
| Q2 2018 | 2.45% |
| Q1 2018 | -11.16% |
| Q4 2017 | -8.65% |
| Q3 2017 | 21.51% |
| Q2 2017 | -9.09% |
| Q1 2017 | 1.94% |
| Q4 2016 | -7.79% |
| Q3 2016 | 5.68% |
| Q2 2016 | -11.15% |
| Q1 2016 | -0.37% |